I adopted a holistic approach in providing care to heart failure patients including those with advanced disease, who have received a heart transplant or mechanical circulatory support device. I also provide care to patients with cardiac amyloidosis and pulmonary hypertension. I will be your partner as we work in a multidisciplinary setting to offer the highest level of care based on evidence-based practices. I will advocate for you as we navigate the various treatment options that are available to you. My mission is to maximally improve the quality of your life with you as an active participant in the management of your illness.
Dr. Ebong is an advanced heart failure and transplant cardiologist who provides care for patients with cardiomyopathies of various etiologies, including cardiac amyloidosis and pulmonary hypertension. She also offers care to adult patients who have received a heart transplant or mechanical circulatory support device. Dr. Ebong has a special clinical interest in cardiac amyloidosis and heart failure in preganancy.
Dr. Ebong performs epidemiological and clinical research focused on heart failure, including gender and racial disparities that influence heart failure outcomes. She has a special interest in heart failure among women especially during pregnancy and the postmenopausal period. Her research works also include outcomes research related to cardiac amyloidosis.
M.B.B.S., Medicine and Surgery, University of Nigeria, Enugu, Nigeria 2000
M.S., Wake Forest University Graduate School of Medicine, Enugu, Nigeria 2012
Internal Medicine, Cleveland Clinic Health System, Cleveland OH 2005-2006
Internal Medicine, Cleveland Clinic Health System, Cleveland OH 2006-2008
Cardiovascular Disease, University of Arizona, Tucson AZ 2015-2018
Advanced Heart Failure, Transplant Cardiology and Mechanical Circulatory Support, University of Chicago, Chicago IL 2018-2019
Program to Increase Diversity Among Individuals Engaged in Health-Related Research on Cardiovascular Disease Comorbidities, Genetics, and Epidemiology Small Research Project Award, 2021
Quality Initiative/Process Improvement Project Award for developing a Cardiac Amyloidosis Program, Accreditation Foundation Committee of the American College of Cardiology Foundation, 2021
MESA Young Investigator Award, 2014
Appiah D, Farias RM, Olokede OA, Nwabuo CC, Bhende KM, Ebong IA, Byrd TL, Nair N. The influence of individual and neighborhood-level characteristics on rural-urban disparities in cardiovascular disease mortality among U.S. women diagnosed with breast and gynecologic cancers. Gynecol Oncol. 2021 May;161(2):483-490. doi:10.1016/j.ygyno.2020.11.023. Epub 2021 Mar 6. PMID:33750605.
Appiah D, Nwabuo CC, Ebong IA, Wellons MF, Winters SJ. Trends in Age at Natural Menopause and Reproductive Life Span Among US Women, 1959-2018. JAMA. 2021 Apr 6;325(13):1328-1330. doi:10.1001/jama.2021.0278. PMID:33821908.
Ebong IA, Wilson MD, Bertoni AG, Appiah D, Polonsky T, Michos ED, Ballantyne C, Chang P. High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study. Menopause. 2021 Jan 4;28(3):284-291. doi:10.1097/GME.0000000000001705. PMID:33399316.
Ebong I, Breathett K. The Cardiovascular Disease Epidemic in African American Women: Recognizing and Tackling a Persistent Problem. J Womens Health (Larchmt). 2020 Jul;29(7):891-893. doi:10.1089/jwh.2019.8125. Epub 2019 Oct 29. PMID:31661348.
Appiah D, Nwabuo CC, Owoade DR, Samad J, Ebong I, Winters SJ. Family history of premature myocardial infarction modifies the associations between bilateral oophorectomy and cardiovascular disease mortality in a US national cohort of postmenopausal women. Menopause. 2020 Jun;27(6):658-667. doi:10.1097/GME.0000000000001522. PMID:32132444.
Avery R, Ebong I, Skaria R, Day K, Miller C, Juneman E, Oliva I, Friedman M, Maltais S, Khalpey Z. Preoperative Risk Stratification of Right Ventricular Function Utilizing Cardiac Magnetic Resonance Imaging Compared With Echocardiographic and Hemodynamic Parameters. ASAIO J. 2020 May;66(5):547-552. doi:10.1097/MAT.0000000000001046. PMID:31335372.
Narang N, Chung B, Nguyen A, Kalathiya RJ, Laffin LJ, Holzhauser L, Ebong IA, Besser SA, Imamura T, Smith BA, Kalantari S, Raikhelkar J, Sarswat N, Kim GH, Jeevanandam V, Burkhoff D, Sayer G, Uriel N. Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart Failure. J Card Fail. 2020 Feb;26(2):128-135. doi:10.1016/j.cardfail.2019.08.004. Epub 2019 Aug 21. PMID:31442494.
Ebong I, Mazimba S, Breathett K. Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making. Curr Heart Fail Rep. 2019 Dec;16(6):274-284. doi:10.1007/s11897-019-00447-w. PMID:31741231.
Ebong IA, Sayer G, Kim G, Jeevanandam V, Baker T, Becker Y, Fung J, Charlton M, Te H, Josephson M, Uriel N. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 Sep;38(9):997-999. doi:10.1016/j.healun.2019.06.017. Epub 2019 Jun 19. PMID:31495411.
Avery R, Ebong I, Skaria R, Day K, Miller C, Juneman E, Oliva I, Friedman M, Maltais S, Khalpey Z. Preoperative Risk Stratification of Right Ventricular Function Utilizing Cardiac Magnetic Resonance Imaging Compared With Echocardiographic and Hemodynamic Parameters. ASAIO J. 2019, Jul 12. doi: 10.1097/MAT.0000000000001046